All Stories

  1. Art of Making Artificial Liver: Depicting Human Liver Biology and Diseases in Mice

    Article • Seminars in Liver Disease, February 2020, Thieme Publishing Group

    Takeshi Saito

  2. Special Issue "IFN-Independent ISG Expression and its Role in Antiviral Cell-Intrinsic Innate Immunity"

    Article • Viruses, October 2019, MDPI AG

    Takeshi Saito

  3. Development of Capsular Fibrosis Beneath the Liver Surface in Humans and Mice

    Article • Hepatology, August 2019, Wiley

    Takeshi Saito

  4. Hepatic IFN-Induced Protein with Tetratricopeptide Repeats Regulation of HCV Infection

    Article • Journal of Interferon & Cytokine Research, March 2019, Mary Ann Liebert Inc

    Takeshi Saito

  5. Regulation of Hepatitis C Virus Infection by Cellular Retinoic Acid Binding Proteins through the Modulation of Lipid Droplet Abundance

    Article • Journal of Virology, February 2019, ASM Journals

    Takeshi Saito

  6. Dual modulation of human hepatic zonation via canonical and non-canonical Wnt pathways

    Article • Experimental & Molecular Medicine, December 2017, Springer Science + Business Media

    Takeshi Saito

  7. Reply

    Article • Gastroenterology, July 2017, Elsevier

    Takeshi Saito

  8. Detection of Occult Hepatitis C Virus Infection in Patients Who Achieved a Sustained Virologic Response to Direct-Acting Antiviral Agents for Recurrent Infection After Liver Transplantation

    Article • Gastroenterology, February 2017, Elsevier

    Takeshi Saito

  9. Hepatic angiosarcoma with clinical and histological features of Kasabach-Merritt syndrome

    Article • World Journal of Gastroenterology, January 2017, Baishideng Publishing Group Co., Limited (formerly WJG Press)

    Takeshi Saito

  10. Comparison of Demographic and Clinical Characteristics of Hispanic and Asian Chronic Hepatitis B Patients in Southern California

    Article • Journal of Clinical Gastroenterology, August 2016, Wolters Kluwer Health

    Takeshi Saito

  11. Organ system view of the hepatic innate immunity in HCV infection

    Article • Journal of Medical Virology, May 2016, Wiley

    Takeshi Saito

  12. Retinoid regulation of antiviral innate immunity in hepatocytes

    Article • Hepatology, January 2016, Wiley

    Takeshi Saito

  13. An Internally Translated MAVS Variant Exposes Its Amino-terminal TRAF-Binding Motifs to Deregulate Interferon Induction

    Article • PLoS Pathogens, July 2015, PLOS

    Takeshi Saito

  14. Novel antiviral host factor, TNK1, regulates IFN signaling through serine phosphorylation of STAT1

    Article • Proceedings of the National Academy of Sciences, January 2014, Proceedings of the National Academy of Sciences

    Takeshi Saito

  15. Innate Immune Tolerance and the Role of Kupffer Cells in Differential Responses to Interferon Therapy Among Patients With HCV Genotype 1 Infection

    Article • Gastroenterology, February 2013, Elsevier

    Takeshi Saito

  16. Isolated arterioportal fistula presenting with variceal hemorrhage

    Article • World Journal of Gastroenterology, January 2013, Baishideng Publishing Group Co., Limited (formerly WJG Press)

    Takeshi Saito

  17. RNase L releases a small RNA from HCV RNA that refolds into a potent PAMP

    Article • RNA, September 2010, Cold Spring Harbor Laboratory Press

    Takeshi Saito

  18. Innate immunity induced by composition-dependent RIG-I recognition of hepatitis C virus RNA

    Article • Nature, July 2008, Springer Science + Business Media

    Michael Gale, Jr., Takeshi Saito

  19. Differential recognition of double-stranded RNA by RIG-I–like receptors in antiviral immunity: Figure 1.

    Article • The Journal of Experimental Medicine, June 2008, Rockefeller University Press

    Takeshi Saito

  20. Regulation of innate immunity against hepatitis C virus infection

    Article • Hepatology Research, November 2007, Wiley

    Takeshi Saito

  21. Principles of intracellular viral recognition

    Article • Current Opinion in Immunology, February 2007, Elsevier

    Takeshi Saito

  22. Regulation of innate antiviral defenses through a shared repressor domain in RIG-I and LGP2

    Article • Proceedings of the National Academy of Sciences, January 2007, Proceedings of the National Academy of Sciences

    Takeshi Saito

  23. Viral and therapeutic control of IFN-β promoter stimulator 1 during hepatitis C virus infection

    Article • Proceedings of the National Academy of Sciences, April 2006, Proceedings of the National Academy of Sciences

    Takeshi Saito

  24. Translational enhancement of HCV RNA genotype 1b by 3′-untranslated and envelope 2 protein-coding sequences

    Article • Virology, February 2006, Elsevier

    Dr Kenichi Morikawa, Takeshi Saito

  25. Sequence analysis of PePHD within HCV E2 region and correlation with resistance of interferon therapy in Japanese patients infected with HCV genotypes 2a and 2b

    Article • The American Journal of Gastroenterology, June 2003, Nature

    Dr Kenichi Morikawa, Takeshi Saito

  26. A case of autoimmune pancreatitis responding to steroid therapy

    Article • Pancreatology, January 2002, Elsevier

    Takeshi Saito